• Sequana Medical wins Best Technology Award for alfapump® at European Mediscience Awards

    Friday June 16th 2023

  • With the platform Startup.Flanders, Flanders claims its place among international start-up ecosystems

    Friday June 16th 2023

  • Confo Therapeutics enters into research collaboration for GPCR-targeting antibody discovery with AbCellera

    Friday June 16th 2023

  • Biocartis announces planned operational reorganization and cost reduction program

    Friday June 16th 2023

  • Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer

    Friday June 16th 2023

  • Mithra announces new positive preclinical data from CSF-1R inhibitor program

    Thursday June 15th 2023

  • My Pathomation new release at the ECDP

    Wednesday June 14th 2023

  • Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board

    Tuesday June 13th 2023

  • Your news here?

  • ΛCTIV by Aphea.Bio® launched in Poland

    Monday June 12th 2023

  • Oxurion finalizes enrollment in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema

    Monday June 12th 2023

  • SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance

    Wednesday June 7th 2023


Strategic Partners